Imunon (IMNN) Profit After Tax (2010 - 2026)

Imunon (IMNN) has 17 years of Profit After Tax data on file, last reported at -$4.2 million in Q1 2026.

• Quarterly Profit After Tax fell 2.38% year-over-year to -$4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.6 million (up 18.14% YoY) and the FY2025 annual result came in at -$14.5 million, up 22.15% from the prior year.
• Profit After Tax was little changed at -$4.2 million in Q1 2026, from -$4.2 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$2.7 million in Q2 2025 to a low of -$13.2 million in Q4 2022.
• A 5-year average of -$5.5 million and a median of -$4.8 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax plunged 213.47% — and 2023, when it soared 63.06%.
• Tracing IMNN's Profit After Tax over 5 years: stood at -$13.2 million in 2022, then soared by 63.06% to -$4.9 million in 2023, then rose by 17.0% to -$4.1 million in 2024, then fell by 3.4% to -$4.2 million in 2025, then declined by 0.12% to -$4.2 million in 2026.
• The last three Profit After Tax figures came in at -$4.2 million (Q1 2026), -$4.2 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.